China CDC and the BC Centre for Excellence in HIV/AIDS strengthen their partnership in support of Treatment as Prevention¨ to curb the impact of HIV/AIDS
Madrid, Spain | FLAVIA NASSAKA | A global HIV conference opened on Oct.22 in Madrid, Spain bringing together researchers to discuss strides made in prevention of infections. Dubbed HIV Research for Prevention (HIVR4P) 2018, the week long event which happens every two years will focus on several new prevention innovations. The new innovations are Pre-Exposure
Global HIV prevention conference kicks off in Spain Read More »
The past few years have been a rollercoaster for those of us most impacted by HIV. The use of pre-exposure prophylaxis (PrEP) by people who are HIV-negative has gone from being discredited and shamed to become one of the keystones of a renewed and revitalized push to “end the HIV epidemic”. The other life-changing piece
It’s time for Toronto to step up: Let’s become a UNAIDS Fast-Track City Read More »
Enacted in 1989, Illinois’ HIV Criminal Transmission Law has undergone minor revisions since then, but remains no less controversial. In the era of U=U (Undetectable=Untransmittable), PrEP, treatment as prevention (TasP, e.g., HPTN 052 and other studies), as well as enlightenment about HIV in general, it is time to reconsider the consequences of this law. I
He Said, She Said — and What the Law Says Read More »
(CNN) – HIV pre-exposure prophylaxis or PrEP, the use of drugs to prevent HIV infection, among men who have sex with men can significantly reduce new infections across an entire population of men, a new study finds. Based on introduction of the intervention, HIV infections diagnosed in men who have sex with men in the
PrEP can ‘significantly’ reduce HIV rates across populations, study says Read More »
Ten years ago, the BC-CfE officially launched the Pharmacovigilance Initiative to closely monitor the safety of HIV antiretroviral drug treatment.
A decade of effective drug safety monitoring led by the BC-CfE Read More »
In a fast-evolving fight against HIV, public-health workers have a powerful new ally: Most Americans at risk of contracting the virus carry powerful smartphones that they check again and again over the course of the day. In recent years, we’ve seen revolutionary advances in HIV prevention that could help us achieve a sustained decline in
Scientists have a new weapon against HIV: your phone Read More »
The Momentum Health Study reveals the most common reasons for testing-or not testing for HIV-among gay, bisexual and other men who have sex with men.
BC-CfE study uncovers reasons for some in gay and bi community not accessing HIV testing Read More »
The ADAP Advocacy Association hosted its annual conference in late September, and it covered many subject areas along this year’s official theme, “Mapping a New Course to Protect the Public Health Safety Net.” The AIDS Drug Assistance Program, which was first established by Congress to pay for Retrovir (zidovudine, AZT) in 1987, was then incorporated
AIDS Drug Assistance Programs Must Navigate Costs and Needs of People With HIV Read More »
Gregg Gonsalves took a wild, meandering path to the Ivory Tower. His route to becoming a professor at Yale started in street protests and spanned the globe. On Thursday he was honored with a prestigious MacArthur Fellowship. Gonsalves is one of this year’s MacArthur “geniuses.” The award from the John D. and Catherine T. MacArthur
A Global Health Evangelist Is Shocked To Hear He’s A ‘Genius’ Read More »
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
